The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’
Abstract
Background and aim: The aim of this study was to illustrate the present role of transsphenoidal surgery as primary therapy in GH-secreting adenomas, and to compare the results concerning control of disease with previous series using older criteria of cure. Method: We report on a consecutive series of 688 acromegalic patients treated over a time period of 19 years. Biochemical cure was defined as normalisation of basal GH level, suppression of GH levels to below 1 ng/ml during an oral glucose load and normalisation of IGF-I levels. Of the 506 patients undergoing primary transsphenoidal surgery, a total of 57.3% postoperatively fulfilled the criteria used. Results: The rate of biochemical ‘cure’ correlated with the magnitude of the initial GH levels, the tumour size and invasion. The overall complication rate was below 2%. Mortality in this series was 0.1% (1 of 688). During a follow-up period of 10.7 years only two recurrences (0.4%) occurred. However, in the patients treated by transcranial surgery and by repeat surgery the cure rate was found to be relatively low (5.2 and 21.3% respectively). Conclusions: These data suggest that surgery remains with very few exceptions the primary treatment of acromegaly for (i) a high cure rate, (ii) low morbidity, (iii) low recurrence rate and (iv) immediate decline of GH. Based on current criteria of cure, recurrences are uncommon. However, cure by surgery alone is improbable in patients harbouring extended, invasive tumours with high secretory activity, in whom further adjuvant treatment is mandatory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Journal of Laboratory and Clinical Medicine
(2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(04)00026-5 · Cited by 1,156
Criteria for Cure of Acromegaly: A Consensus Statement
Giustina, A. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.526 · Cited by 987
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study1
Orme, S. M., McNally, R. J. Q., Cartwright, R. A., & Belchetz, P. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5007 · Cited by 805
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly1
Swearingen, B., Barker, F. G., Katznelson, L., Biller, B. M. K., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P. M., & Zervas, N. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.10.5222 · Cited by 586
Determinants of clinical outcome and survival in acromegaly
Rajasoorya, C., Holdaway, I. M., Wrightson, P., Scott, D. J., & Ibbertson, H. K. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03789.x · Cited by 565
An audit of outcome of treatment in acromegaly
(1993) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068816 · Cited by 466
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly
Swearingen, B. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3419 · Cited by 400
Abosch, A., Tyrrell, J. B., Lamborn, K. R., Hannegan, L. T., Applebury, C. B., & Wilson, C. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3411 · Cited by 361
Guidelines for Acromegaly Management
Melmed, S., Casanueva, F. F., Cavagnini, F., Chanson, P., Frohman, L., Grossman, A., Ho, K., Kleinberg, D., Lamberts, S., Laws, E., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-011841 · Cited by 343
Kreutzer, J., Vance, M. L., Lopes, M. B. S., & Laws, E. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4072 · Cited by 341
Long‐term outcome and mortality after transsphenoidal adenomectomy for acromegaly
Beauregard, C., Truong, U., Hardy, J., & Serri, O. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01679.x · Cited by 300
Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience
Ahmed, Elsheikh, Stratton, Page, Adams, & Wass (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00760.x · Cited by 291
Freda, P. U., Wardlaw, S. L., & Post, K. D. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.3.0353 · Cited by 281
Bevan, J. S., Atkin, S. L., Atkinson, A. B., Bouloux, P.-M., Hanna, F., Harris, P. E., James, R. A., McConnell, M., Roberts, G. A., Scanlon, M. F., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-012012 · Cited by 279
Ross, D. A., & Wilson, C. B. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.6.0854 · Cited by 260
Newman, C. B., Melmed, S., Snyder, P. J., Young, W. F., Boyajy, L. D., Levy, R., Stewart, W. N., Klibanski, A., Molitch, M. E., & Gagel, R. F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673422 · Cited by 245
Surgical Management of Acromegaly
Fahlbusch, R., Honegger, J., & Buchfelder, M. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30208-1 · Cited by 201
Self-citationOutcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure
Sheaves, R., Jenkins, P., Blackburn, P., Huneidi, A. H., Afshar, F., Medbak, S., Grossman, A. B., Besser, G. M., & Wass, J. A. H. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8370847.x · Cited by 199
Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon
Gittoes, N. J. L. (1999) · QJM · doi:10.1093/qjmed/92.12.741 · Cited by 176
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study
Orme, S. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2730 · Cited by 173
Lissett, Peacey, Laing, Tetlow, Davis, J. R., & Shalet, S. M. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00581.x · Cited by 148
Improvement of pituitary function after surgical decompression for pituitary tumor apoplexy
ARAFAH, B. M., HARRINGTON, J. F., MADHOUN, Z. T., & SELMAN, W. R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-323 · Cited by 134
Results of surgical treatment for growth hormone-secreting pituitary adenomas
Davis, D. H., Laws, E. R., Ilstrup, D. M., Speed, J., Caruso, M., Shaw, E. G., Abboud, C. F., Scheithauer, B. W., Root, L. M., & Schleck, C. D. (1993) · Journal of neurosurgery · doi:10.3171/jns.1993.79.1.0070 · Cited by 124
Ayuk, J., Stewart, S. E., Stewart, P. M., & Sheppard, M. C. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011913 · Cited by 95
Peacey, S. R., Toogood, A. A., Veldhuis, J. D., Thorner, M. O., & Shalet, S. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7154 · Cited by 83
MEDICAL THERAPY FOR ACROMEGALY
Newman, C. B. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70062-1 · Cited by 82
Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas
Nelson, A. T., Tucker, H. S. G., & Becker, D. P. (1984) · Journal of neurosurgery · doi:10.3171/jns.1984.61.3.0577 · Cited by 66
Arafah, B. M., Rosenzweig, J. L., Fenstermaker, R. A., Salazar, R., McBride, C. E., & Selman, W. R. (1987) · PubMed · Cited by 47
A Dissecting Aneurysm of the Posteroinferior Cerebellar Artery: Case Report
Jafar, J. J., Kamiryo, T., Chiles, B. W., & Nelson, P. K. (1998) · Neurosurgery · doi:10.1097/00006123-199808000-00107 · Cited by 41
Arafah, B. M., Brodkey, J. S., Manni, A., Velasco, M. E., Kaufman, B., & Pearson, O. H. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb01583.x · Cited by 32
Effectiveness of Secondary Transnasal Surgery in GH-Secreting Pituitary Macroadenomas
Kurosaki, M., Luedecke, D. K., & Abe, T. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.635 · Cited by 29
Valdemarsson, S. V., Bramnert, M., Cronquist, S., Elner, Å., Eneroth, C. ‐., Hedner, P., Lindvall-Axelsson, M., Nordström, C., & Strömblad, L. ‐. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00405.x · Cited by 24
Valdemarsson, S. V., Ljunggren, S., Bramnert, M., Norrhamn, O., & Nordström, C. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00667.x · Cited by 22
The place of pegvisomant in the acromegaly treatment algorithm
Paisley, A. N., Trainer, P. J., & Drake, W. M. (2004) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.03.039 · Cited by 8
Cited by
Acromegaly: An Endocrine Society Clinical Practice Guideline
Katznelson, L., Laws, E. R., Melmed, S., Molitch, M. E., Murad, M. H., Utz, A., & Wass, J. A. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2700 · Cited by 1,786
A Consensus on Criteria for Cure of Acromegaly
Giustina, A., Chanson, P., Bronstein, M. D., Klibanski, A., Lamberts, S., Casanueva, F. F., Trainer, P., Ghigo, E., Ho, K., & Melmed, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2670 · Cited by 783
Guidelines for Acromegaly Management: An Update
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 764
Saeger, W., Lüdecke, D. K., Buchfelder, M., Fahlbusch, R., Quabbe, H.-J., & Petersenn, S. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02326 · Cited by 583
Self-citationDehdashti, A. R., Ganna, A., Karabatsou, K., & Gentili, F. (2008) · Neurosurgery · doi:10.1227/01.neu.0000297072.75304.89 · Cited by 408
Metadata
- Authors
- Nomikos, P., Buchfelder, M., & Fahlbusch, R.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03
- Volume
- 152
- Issue
- 3
- Pages
- 379-387
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2142493227
- Cited by
- 500
- References
- 35
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.